BEXIMCO PHARMACEUTICALS LTD

Beximco Pharmaceuticals Ltd. Company Introduction

Beximco Pharmaceuticals Ltd. is a leading pharmaceutical manufacturer based in Bangladesh. It is a flagship company of the Beximco Group, one of the largest private sector industrial conglomerates in Bangladesh. Established in 1976, the company commenced commercial operations in 1980.

Beximco Pharmaceuticals Ltd. is primarily a manufacturer (factory). It operates modern, state-of-the-art manufacturing facilities that produce a comprehensive range of generic pharmaceutical products and active pharmaceutical ingredients (APIs). Their product portfolio includes various dosage forms such as tablets, capsules, liquids, creams, ointments, suppositories, and injectables, covering a wide spectrum of therapeutic areas. The company's manufacturing plants are designed and maintained to meet international standards and have received approvals from several global regulatory authorities, including the US FDA, UK MHRA, EU GMP, TGA Australia, and Health Canada.

Beximco Pharmaceuticals Ltd. is a significant exporter of pharmaceuticals from Bangladesh, serving markets across the globe. The company is recognized for its strong focus on quality, research and development, and its commitment to providing accessible healthcare solutions.

Beximco Pharmaceuticals Ltd produces or sells a wide range of pharmaceutical products across various therapeutic categories.

Therapeutic Categories:

Anti-infectives

Cardiovascular System Drugs

Central Nervous System Drugs

Respiratory System Drugs

Gastrointestinal System Drugs

Diabetology Products

Oncology Products

Dermatological Products

Musculoskeletal System Drugs

Vitamins and Minerals

Pain Management Products

Urology Products

Ophthalmology Products

Women's Health Products

Allergy and Immunology Products

Example Products:

Napa (Paracetamol)

Maxpro (Esomeprazole)

Losectil (Omeprazole)

Ciprocin (Ciprofloxacin)

Diaformin (Metformin)

Salbuvent (Salbutamol)

Atorva (Atorvastatin)

Rovista (Rosuvastatin)

Monas (Montelukast)

Sitaglip (Sitagliptin)

Vildaglip (Vildagliptin)

Dapaglip (Dapagliflozin)

Bemsivir (Remdesivir)

Monuvir (Molnupiravir)

Favipira (Favipiravir)

Bextemra (Tocilizumab biosimilar)